These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 33888738)
1. Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses. Chang SY; Huang KY; Chao TL; Kao HC; Pang YH; Lu L; Chiu CL; Huang HC; Cheng TR; Fang JM; Yang PC Sci Rep; 2021 Apr; 11(1):8692. PubMed ID: 33888738 [TBL] [Abstract][Full Text] [Related]
2. Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro. Zhan Y; Ta W; Tang W; Hua R; Wang J; Wang C; Lu W Drug Dev Res; 2021 Dec; 82(8):1124-1130. PubMed ID: 33847382 [TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions. Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP mBio; 2021 Mar; 12(2):. PubMed ID: 33785634 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2. Rowland R; Brandariz-Nuñez A Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876 [TBL] [Abstract][Full Text] [Related]
5. Repositioning of histamine H Ge S; Wang X; Hou Y; Lv Y; Wang C; He H Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607 [TBL] [Abstract][Full Text] [Related]
6. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. Li Q; Zhao Z; Zhou D; Chen Y; Hong W; Cao L; Yang J; Zhang Y; Shi W; Cao Z; Wu Y; Yan H; Li W Peptides; 2011 Jul; 32(7):1518-25. PubMed ID: 21620914 [TBL] [Abstract][Full Text] [Related]
7. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives. Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010 [TBL] [Abstract][Full Text] [Related]
8. Peptide S4 is an entry inhibitor of SARS-CoV-2 infection. Liang Z; Wang J; Zhang H; Gao L; Xu J; Li P; Yang J; Fu X; Duan H; Liu J; Liu T; Ma W; Wu K Virology; 2024 Sep; 597():110149. PubMed ID: 38917689 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19). Nayak SK Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074 [TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2). Xiang Y; Wang M; Chen H; Chen L Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003 [TBL] [Abstract][Full Text] [Related]
12. Withanone from Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804 [TBL] [Abstract][Full Text] [Related]
13. Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor. Kim YS; Chung HS; Noh SG; Lee B; Chung HY; Choi JG Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445310 [TBL] [Abstract][Full Text] [Related]
14. Targeting SARS-CoV-2 Spike Protein/ACE2 Protein-Protein Interactions: a Computational Study. Pirolli D; Righino B; De Rosa MC Mol Inform; 2021 Jun; 40(6):e2060080. PubMed ID: 33904240 [TBL] [Abstract][Full Text] [Related]
15. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411 [TBL] [Abstract][Full Text] [Related]
16. "Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry. Shukla SP; Cho KB; Rustagi V; Gao X; Fu X; Zhang SX; Guo B; Udugamasooriya DG Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445669 [TBL] [Abstract][Full Text] [Related]
17. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells. Caohuy H; Eidelman O; Chen T; Liu S; Yang Q; Bera A; Walton NI; Wang TT; Pollard HB Sci Rep; 2021 Nov; 11(1):22195. PubMed ID: 34773067 [TBL] [Abstract][Full Text] [Related]
18. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19. Muralidar S; Gopal G; Visaga Ambi S J Med Virol; 2021 Sep; 93(9):5260-5276. PubMed ID: 33851732 [TBL] [Abstract][Full Text] [Related]
19. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2. Elrashdy F; Redwan EM; Uversky VN Infect Genet Evol; 2020 Nov; 85():104510. PubMed ID: 32853823 [TBL] [Abstract][Full Text] [Related]
20. Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012. Hoang Vu MP; Nguyen CT; Nguyen le KH; Nguyen TK; Le QM Western Pac Surveill Response J; 2013; 4(2):25-9. PubMed ID: 24015368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]